Article

January 27, 2023

AJMC® in the Press, January 27, 2023

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A study published in the November 2022 issue of The American Journal of Managed Care^® was cited in articles by Earth.com and MedicalXpress. The study, “COVID-19 Surges and Hospital Outcomes in the United States,” found increased hospital mortality odds among non–COVID-19 patients, implying compromised quality of care during COVID-19 surges. Additionally, no large-scale changes were found in discharges to other facilities.

Related Videos

5 experts are featured in this series

5 experts are featured in this series

Christine Funke, MD

John Michael O'Brien, PharmD, MPH

Kathi Henson, MBA, sitting for a video interview

Mike Fazio, Navista, Cardinal Health

1 expert in this video

1 expert in this video

Dr Mingyang Song

Related Content

gene therapy | Image Credit: © RFBSIP - stock.adobe.com

April 30th 2025

Expanding Broader Patient Access to CGTs

Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

FDA approved. | Image Credit: Pawel - stock.adobe.com

April 30th 2025

FDA Approves Nipocalimab for Generalized Myasthenia Gravis

Christina Mattina

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older with generalized myasthenia gravis based on data from the ongoing Vivacity-MG3 study.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

AACR Results Seek Solutions to Precision Medicine Challenges

April 30th 2025

AACR Results Seek Solutions to Precision Medicine Challenges

Results presented on Tuesday at the American Association for Cancer Research annual meeting include data on the combined use of tissue and liquid biopsy, as well as a framework for evaluating multicancer early detection testing.

COA signage | Image Credit: © Maggie L. Shaw

April 29th 2025

Advancing the Art of Medicine Through Partnership

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.

Related Content

gene therapy | Image Credit: © RFBSIP - stock.adobe.com

April 30th 2025

Expanding Broader Patient Access to CGTs

Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

FDA approved. | Image Credit: Pawel - stock.adobe.com

April 30th 2025

FDA Approves Nipocalimab for Generalized Myasthenia Gravis

Christina Mattina

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older with generalized myasthenia gravis based on data from the ongoing Vivacity-MG3 study.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

AACR Results Seek Solutions to Precision Medicine Challenges

April 30th 2025

AACR Results Seek Solutions to Precision Medicine Challenges

Results presented on Tuesday at the American Association for Cancer Research annual meeting include data on the combined use of tissue and liquid biopsy, as well as a framework for evaluating multicancer early detection testing.

COA signage | Image Credit: © Maggie L. Shaw

April 29th 2025

Advancing the Art of Medicine Through Partnership

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions